Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)

Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Newsfile - Sun Apr 7, 10:00PM CDT

Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
DR. RAZA BOKHARI, FORMER EXECUTIVE CHAIRMAN AND CEO OF FSD PHARMA, FILES TWO ADDITIONAL CLAIMS AGAINST THE COMPANY SEEKING RELIEF AND MONETARY DAMAGES EXCEEDING $30.2 MILLION Newswire.ca - Wed Jun 21, 2023

/CNW/ -- Attorneys for Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma (CSE: HUGE, NASDAQ: HUGE) have filed two new claims against his...

HUGE.CN : 0.6800 (-2.86%)
HUGE : 0.5058 (-3.27%)
FSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11 Business Wire - Mon May 8, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis Business Wire - Mon Apr 17, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
FSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023 Business Wire - Wed Apr 12, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
FSD Pharma Announces Filing of Year-End 2022 Results Business Wire - Fri Mar 31, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
FSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of Advisors Business Wire - Thu Mar 30, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder Business Wire - Wed Mar 22, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its Stock Business Wire - Tue Mar 14, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)
Original “Shark” and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory Board Business Wire - Tue Feb 28, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 0.5058 (-3.27%)
HUGE.CN : 0.6800 (-2.86%)

Barchart Exclusives

2 Struggling Stocks to Buy at a Discount Barchart - 40 minutes ago
The decline in fundamentally strong stocks presents an opportunity for investors to capitalize on the future recovery. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot